UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
CJ Healthcare opens anti-hangover research center
CJ Healthcare said Monday that it has opened Korea’s first anti-hangover re...
by Lee Han-soo
|
2017-10-30 15:18
라인
Gilead to encourage switching to Vemlidy with new test
Gilead, which developed new drug Vemlidy (ingredient: tenofovir ala fenamid...
by Lee Hye-seon
|
2017-10-30 13:10
라인
JW Pharma, U Penn cooperate to develop hair loss treatment
JW Pharmaceutical said Monday that it would begin pre-clinical trial for CW...
by Lee Han-soo
|
2017-10-30 12:14
라인
Eli Lilly, KRICT research institute to partner in drug discovery program
Eli Lilly Korea (Chairman: Paul Henry Huibers) said Friday it has partnered...
by Marian Chu
|
2017-10-27 17:30
라인
Seoul Pharma signs $7.67-million export contract to Indonesia
Vice Chairman Park Jong-jeon of Seoul Pharmaceuticals (left) and Piero Bram...
by Constance Williams
|
2017-10-27 16:57
라인
AbbVie’s investigational biologic for psoriasis beats out Humira in trial
AbbVie said Thursday its investigational drug for plaque psoriasis outperfo...
by Marian Chu
|
2017-10-27 16:25
라인
Ildong Pharma to release 1st chronic hepatitis B treatment next month
Ildong Pharmaceutical will release its first chronic hepatitis B therapy of...
by Constance Williams
|
2017-10-26 16:51
라인
Boryung sees strong uptake of hypertension drugs in Korean market
Korean pharmaceutical Boryung said Thursday its line of hypertension drugs,...
by Marian Chu
|
2017-10-26 15:53
라인
‘Misuse, abuse of tramadol-based painkillers need factual survey’
Koreans are probably misusing and abusing tramadol-based pain relievers, re...
by Lee Min-ju
|
2017-10-26 11:35
라인
Dizziness, headache added to precautions for Lixiana
Anti-blood clotting drug Lixiana (ingredient: edoxaban), manufactured by Da...
by Lee Hye-seon
|
2017-10-25 17:50
라인
Korea’s high drug to medical expense ratio needs remedial steps
Korea’s ratio of drug cost to overall medical expense ratio is higher than ...
by Lee Han-soo
|
2017-10-25 10:37
라인
Huons to proceed with phase 3 clinical trials for dry eye treatment
Huons said Tuesday it has received approval from the Ministry of Food and D...
by Lee Han-soo
|
2017-10-24 17:56
라인
Drugmakers to adopt anti-bribery management system ‘ISO 37001’
Korean drugmakers have announced that they would introduce an international...
by Lee Hye-seon
|
2017-10-24 15:59
라인
Roche Korea vows to put patients’ needs first
Roche Korea finalized and presented 39 action plans to realize patient-cent...
by Marian Chu
|
2017-10-24 11:11
라인
GSK gets US approval for shingles vaccine
Following the heels of approval from the European regulatory authorities, G...
by Marian Chu
|
2017-10-24 10:15
라인
Sanofi-Regeneron proves safety of cholesterol drug
Sanofi-Aventis Korea said Monday its cholesterol-lowering injection Praluen...
by Marian Chu
|
2017-10-23 15:32
라인
Korean pharmaceuticals vie to preempt dry eye treatment market
Korean pharmaceutical companies are striving to develop new drugs to treat ...
by Lee Hye-seon
|
2017-10-23 15:31
라인
Novartis Korea increases cost-effectiveness of psoriasis drug
Novartis Korea said Friday its first-in-class drug for severe plaque psoria...
by Marian Chu
|
2017-10-20 17:48
라인
Bullous pemphigoid added to precautions for DPP-4 inhibitors
Antidiabetic drugs of dipeptidyl peptidase-4 (DPP-4) inhibitor series will ...
by Lee Hye-seon
|
2017-10-20 16:02
라인
Roche Korea is Korea’s 8th-best employer this year
Three pharmaceutical companies have put their names on the list of best emp...
by Marian Chu
|
2017-10-20 13:31
-
이전
101
102
103
104
105
106
107
108
109
110
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top